CirculationPub Date : 2026-11-03Epub Date: 2026-09-15DOI: 10.1161/CIRCULATIONAHA.124.072363
Alan de Araujo, Hemaa Sree Kumar, Tao Yang, Emily B Otmanowski, Adriana Alviter Plata, Elliott W Dirr, Nicole R Bearss, David M Baekey, Megan R Dreier, Ivana de la Serna, Darren S Miller, Basak Donertas-Ayaz, Arashdeep Singh, Andrea L Kalinoski, Timothy J Garrett, Brittney Short, Matthew L Anderson, Christopher J Martyniuk, Guillaume de Lartigue, Jasenka Zubcevic
{"title":"Intestinal Serotonergic Vagal Signaling as a Mediator of Microbiota-Induced Hypertension.","authors":"Alan de Araujo, Hemaa Sree Kumar, Tao Yang, Emily B Otmanowski, Adriana Alviter Plata, Elliott W Dirr, Nicole R Bearss, David M Baekey, Megan R Dreier, Ivana de la Serna, Darren S Miller, Basak Donertas-Ayaz, Arashdeep Singh, Andrea L Kalinoski, Timothy J Garrett, Brittney Short, Matthew L Anderson, Christopher J Martyniuk, Guillaume de Lartigue, Jasenka Zubcevic","doi":"10.1161/CIRCULATIONAHA.124.072363","DOIUrl":"10.1161/CIRCULATIONAHA.124.072363","url":null,"abstract":"<p><strong>Background: </strong>Hypertension is a pervasive global health challenge, impacting more than 1 billion individuals worldwide. Despite strides in therapeutic strategies, a significant proportion of patients remain resistant to the currently available therapies. Although conventional treatments predominantly focus on cardiac, renal, and cerebral targets, emerging research underscores the pivotal role of the gut and its microbiota. Yet, the precise mechanisms governing interactions between the gut microbiota and the host blood pressure remain unclear.</p><p><strong>Methods: </strong>We combined fecal microbiota transplantation between normotensive and hypertensive rats, an intersectional genetic strategy in a serotonin receptor 3a (5HT3a) receptor Cre rat line to activate, ablate, and restore serotonin-sensing colonic vagal neurons, in vivo calcium imaging and radiotelemetric blood pressure recordings, and measurements of intestinal serotonin (5-hydroxytryptamine [5-HT]) and 5HT3a receptor signaling in rats and in colonic biopsies from normotensive and hypertensive human subjects (N=5 per group; 36 to 75 years of age).</p><p><strong>Results: </strong>A marked decrease in both intestinal 5-HT and vagal 5HT3a receptor signaling was observed in hypertensive rats and humans, and in rats subjected to fecal microbiota transplantation from hypertensive rats. Leveraging the intersectional genetic strategy in a Cre rat line, we demonstrate that intestinal 5HT3a receptor vagal signaling is a crucial link between the gut microbiota and blood pressure homeostasis and that recovery of 5-HT signaling in colon-innervating vagal neurons can alleviate hypertension.</p><p><strong>Conclusions: </strong>Here, we describe a neural host-microbiota interaction that is mediated by intestinal serotonin (5-HT) signaling via the vagal 5HT3a, which is crucial for maintenance of blood pressure homeostasis. This finding enhances our comprehension of hypertensive pathophysiology and unveils a promising new therapeutic target for combating resistant hypertension associated with gut dysbiosis.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":"1848-1866"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148966863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.083431
Michelle L O'Donoghue
{"title":"A Lasting Legacy: Honoring the Life and Impact of Dr Eugene Braunwald.","authors":"Michelle L O'Donoghue","doi":"10.1161/CIRCULATIONAHA.126.083431","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.083431","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"1753-1754"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.081329
Barry J Maron, Martin S Maron
{"title":"Eugene Braunwald Legacy Series: The Father of Hypertrophic Cardiomyopathy.","authors":"Barry J Maron, Martin S Maron","doi":"10.1161/CIRCULATIONAHA.126.081329","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.081329","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"1762-1765"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.080753
Sha Zeng, Juan Wan, Zhengrong Shi
{"title":"Letter by Zeng et al Regarding Article, \"IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes\".","authors":"Sha Zeng, Juan Wan, Zhengrong Shi","doi":"10.1161/CIRCULATIONAHA.126.080753","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.080753","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"e668"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.081332
Erin A Bohula
{"title":"Eugene Braunwald Legacy Series: Lipid Lowering and the Era of Prevention.","authors":"Erin A Bohula","doi":"10.1161/CIRCULATIONAHA.126.081332","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.081332","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"1771-1773"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.081330
Scott D Solomon
{"title":"Eugene Braunwald Memorial Series: Fighting and Winning the War on Heart Failure.","authors":"Scott D Solomon","doi":"10.1161/CIRCULATIONAHA.126.081330","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.081330","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"1766-1768"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-09-08DOI: 10.1161/CIRCULATIONAHA.126.078415
Jingdong Wu, Chunyan Yang, Donghui Wu, Shaoqi Zhu, Yiran Liu, Yang Yang, Ze Xu, Yitong Xu, Xiaochun Yang, Lichao Mao, Jinxuan Chen, Huan Wang, Dongyu Zhao, Shiqiang Wang, Chao Tang, Bin Zhou, Yang Zhao
{"title":"Overcoming Intrinsic Barriers in Myofibroblasts Permits Efficient Cardiac Reprogramming After Infarction.","authors":"Jingdong Wu, Chunyan Yang, Donghui Wu, Shaoqi Zhu, Yiran Liu, Yang Yang, Ze Xu, Yitong Xu, Xiaochun Yang, Lichao Mao, Jinxuan Chen, Huan Wang, Dongyu Zhao, Shiqiang Wang, Chao Tang, Bin Zhou, Yang Zhao","doi":"10.1161/CIRCULATIONAHA.126.078415","DOIUrl":"10.1161/CIRCULATIONAHA.126.078415","url":null,"abstract":"<p><strong>Background: </strong>Direct reprogramming of cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) holds promise as a therapeutic strategy for heart regeneration. After myocardial infarction (MI), resident quiescent CFs (QCFs) activate and differentiate into myofibroblasts (MFs) in the infarcted region that drive pathological cardiac fibrosis. Converting these injury-activated MFs into iCMs could simultaneously alleviate fibrosis and replenish lost cardiomyocytes. However, whether the marked heterogeneity of CFs in the infarcted heart, and in particular the activation of QCFs into MFs, creates an intrinsic barrier that limits the reprogramming of these injury-activated MFs remains unknown.</p><p><strong>Methods: </strong>To define the molecular basis of this heterogeneity, we purified PDGFRα<sup>+</sup> CFs and used Postn lineage tracing to distinguish injury-activated MFs from quiescent CFs, enabling matched comparison of their reprogramming competence and single-cell RNA sequencing (scRNA-seq) profiling of post-MI CF subpopulations. A targeted in vitro shRNA screen was conducted against 9 MF-enriched TFs as candidate molecular barriers for cardiac reprogramming. The lead candidate was validated in mouse MFs, human iPSC-derived MFs, primary human MFs, and in vivo using dual-recombinase-mediated lineage tracing. Mechanistic insights were gained through integrated bulk RNA-seq, scRNA-seq and Cleavage Under Targets and Tagmentation (CUT&Tag), together with functional assays including DNA-binding-deficient and domain-swap MEOX1 mutants.</p><p><strong>Results: </strong>We identified the upregulated transcription factor MEOX1, a known fibrosis determinant downstream of the key post-MI cytokines transforming growth factor-beta 1 and interleukin-1 beta, as the principal molecular barrier responsible for the profound reprogramming resistance of MFs. MEOX1 knockdown markedly enhanced reprogramming efficiency in both mouse and human MFs and enabled GATA4-free reprogramming combinations. This inhibition depended on the transcriptional activation activity of MEOX1, as disrupting its DNA-binding domain or fusing it to a repressor domain rescued reprogramming. Integrated scRNA-seq and CUT&Tag analyses revealed that MEOX1 binds and stabilizes a fibrotic, MF-defining transcriptional program that antagonizes the cardiogenic program while also modulating the inflammatory response; its knockdown disrupted this fibrotic network to favor iCM fate acquisition. Using stringent dual-recombinase lineage tracing, we demonstrated that MEOX1 knockdown enables highly efficient in vivo MF-to-iCM conversion, leading to significant reductions in cardiac fibrosis and substantial improvement in cardiac function after MI.</p><p><strong>Conclusions: </strong>Our study identifies pathological MEOX1 upregulation as a key mechanism underlying the reprogramming resistance of post-MI mouse MFs and activated human MFs. Overcoming this barrier achieves unprecedented, lin","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":"1806-1828"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148905271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.080310
Hongliang Zhang, Wence Shi, Yongjian Wu
{"title":"Letter by Zhang et al Regarding Article, \"IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes\".","authors":"Hongliang Zhang, Wence Shi, Yongjian Wu","doi":"10.1161/CIRCULATIONAHA.126.080310","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.080310","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"e666-e667"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CirculationPub Date : 2026-11-03Epub Date: 2026-11-02DOI: 10.1161/CIRCULATIONAHA.126.081327
Paula A Johnson
{"title":"Mentoring a Generation.","authors":"Paula A Johnson","doi":"10.1161/CIRCULATIONAHA.126.081327","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.081327","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"154 18","pages":"1769-1770"},"PeriodicalIF":41.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}